These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 28618942)
1. Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: A systematic review and meta-analysis. Liu G; Xiong D; Xiao R; Huang Z Tumour Biol; 2017 Jun; 39(6):1010428317707424. PubMed ID: 28618942 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis. Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884 [TBL] [Abstract][Full Text] [Related]
3. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435 [TBL] [Abstract][Full Text] [Related]
4. Prognostic role of cyclin B1 in solid tumors: a meta-analysis. Ye C; Wang J; Wu P; Li X; Chai Y Oncotarget; 2017 Jan; 8(2):2224-2232. PubMed ID: 27903976 [TBL] [Abstract][Full Text] [Related]
5. Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis. Chen S; He H; Wang Y; Liu L; Liu Y; You H; Dong Y; Lyu J BMC Cancer; 2018 Aug; 18(1):838. PubMed ID: 30126359 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma. Tokunaga R; Imamura Y; Nakamura K; Ishimoto T; Nakagawa S; Miyake K; Nakaji Y; Tsuda Y; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Saeki H; Yoshida N; Oki E; Watanabe M; Oda Y; Bass AJ; Maehara Y; Baba H Oncotarget; 2016 Apr; 7(15):19748-61. PubMed ID: 26933914 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis. Li L; Wu D; Yu Q; Li L; Wu P Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of HOXA13 in solid tumors: A meta-analysis. Wen Y; Shu F; Chen Y; Chen Y; Lan Y; Duan X; Zhao SC; Zeng G Clin Chim Acta; 2018 Aug; 483():64-68. PubMed ID: 29678634 [TBL] [Abstract][Full Text] [Related]
9. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis. Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619 [TBL] [Abstract][Full Text] [Related]
10. Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis. Xu T; Jin Z; Yuan Y; Zheng H; Li C; Hou W; Guo Q; Hua B PLoS One; 2016; 11(12):e0168408. PubMed ID: 28036326 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis. Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469 [TBL] [Abstract][Full Text] [Related]
12. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis. Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237 [TBL] [Abstract][Full Text] [Related]
13. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor. Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis. Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of long non-coding RNA UCA1 in human solid tumors. Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147 [TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis. Templeton AJ; Diez-Gonzalez L; Ace O; Vera-Badillo F; Seruga B; Jordán J; Amir E; Pandiella A; Ocaña A Cancer Treat Rev; 2014 Oct; 40(9):1048-55. PubMed ID: 25217796 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy. Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of hepatoma-derived growth factor in solid tumors of Eastern Asia: a systematic review and meta- analysis. Bao CH; Liu K; Wang XT; Ma W; Wang JB; Wang C; Jia YB; Wang NN; Tan BX; Song QX; Cheng YF Asian Pac J Cancer Prev; 2015; 16(5):1803-11. PubMed ID: 25773828 [TBL] [Abstract][Full Text] [Related]
20. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis. Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]